Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human FPR3 Stable Cell Line

    [CAT#: S01YF-0923-PY147]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    FPR3
    Target Family
    N-formylpeptide Family
    Target Protein Species
    Human
    Host Cell Type
    MDA-MB-231;MDA-MB-468;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    Infectious Research;CNS Research
    Related Diseases
    Anaerobic Meningitis;Rubeosis Iridis
    Gene ID
    Human: 2359
    UniProt ID
    Human: P25089

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    FPR3, while less studied than its counterparts FPR1 and FPR2, has shown promise in several research domains. For instance, FPR3 has been identified as a key immune-related biomarker predicting a poor prognosis for breast cancer, suggesting its potential as a therapeutic target. Moreover, its role in the immune response against bacterial infections has been highlighted, with studies showing that FPR3 responds to peptides from bacterial proteins, driving an avoidance response in mice. This suggests potential applications in the development of novel antimicrobial therapies or vaccines.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human FPR3 Stable Cell Line (S01YF-0923-PY147). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Lisa (Verified Customer)

    How does FPR3 relate to the epithelial barrier in cell lines? Mar 20 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    While direct research on FPR3's role in the epithelial barrier is limited, proteins like LSR, which are associated with tricellular tight junctions, contribute to the epithelial barrier and malignancy in certain cell lines, suggesting that FPR3 might have similar functions. Mar 20 2023

    chat Michael (Verified Customer)

    Are there any known malignancies associated with FPR3 in cell line research? Apr 21 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Direct associations between FPR3 and malignancies in cell line research are limited. However, proteins associated with tight junctions, like LSR, have been linked to malignancies in pancreatic cancer cell lines. Apr 21 2023

    Published Data

    Fig.1 FPR3 knockdown did not alter cell migration and invasion.

    In Transwell experiments, co-transfecting PRSS22 and FPR2 siRNA resulted in a notable decrease in both migration and invasion capabilities. Interestingly, the knockdown of FPR1 or FPR3 had no discernible impact on the migration and invasion of BC cells, as evidenced by the data from three separate experiments (Scale bars, 100 μm). The results are presented as the mean± SD, with statistical significance indicated as *P<0.05, while ns denotes no significance.

    Ref: Song, Lin, et al. "E2F1-initiated transcription of PRSS22 promotes breast cancer metastasis by cleaving ANXA1 and activating FPR2/ERK signaling pathway." Cell Death & Disease 13.11 (2022): 982.

    Pubmed: 36414640

    DOI: 10.1038/s41419-022-05414-3

    Research Highlights

    Hu T, Chen X. "Role of neutrophil extracellular trap and immune infiltration in atherosclerotic ." Medicine, 2023.
    The instability of atherosclerotic plaques has been linked to an increased risk of acute coronary syndrome. Recent research has highlighted the important role of neutrophil extracellular traps (NETs) in the formation and development of these plaques. To address the need for early detection and prevention of plaque erosion or disruption, a study was conducted to identify novel diagnostic biomarkers for unstable plaques. By analyzing gene expression and performing pathway and network analyses, the study identified 8 differential NET-related genes involved in immune responses and smooth muscle contractility, and 4 of these genes were found to be capable of distinguishing unstable plaques. Furthermore, an understanding of immune cell infiltration and regulatory factors such as miRNAs and transcription factors may aid in the identification and prevention of plaque rupture. The 4 identified diagnostic genes (AQP9, C5AR1, FPR3, and SIGLEC9) and associated immune cell subsets provide promising candidates for early recognition and prevention of atherosclerotic plaque complications.
    Pubmed: 37747003   DOI: 10.1097/MD.0000000000034918

    Hashemi Karoii D, et al. "Altered G-Protein Transduction Protein Gene Expression in the Testis of Infertile ." DNA and cell biology, 2023.
    Recent studies have revealed that the G-protein-coupled receptor (GPCR) superfamily plays a critical role in maintaining ion-water homeostasis in sperm and Sertoli cells, as well as in the development of germ cells, the formation of the blood barrier, and the maturation of sperm. Microarray and bioinformatics analysis of 3513 sperm and Sertoli cell genes revealed changes in the expression of GPCR, guanyl-nucleotide exchange factor, membrane traffic protein, and small GTPase genes in three human cases of non-obstructive azoospermia (NOA). Upregulation of GOLGA8IP, OR2AT4, PHKA1, A2M, OR56A1, SEMA3G, LRRC17, APP, ARHGAP33, RABGEF1, NPY2R, GHRHR, LTB4R2, GRIK5, OR6K6, NAPG, OR6C65, VPS35, FPR3, and ARL4A, and downregulation of MARS, SIRPG, OGFR, GPR150, LRRK1, and NGEF were observed. Sertoli cells in NOA cases also showed an increase in expression of GBP3, GBP3, TNF, TGFB3, and CLTC, and a decrease in expression of PAQR4, RRAGD, RAC2, SERPINB8, IRPB1, MRGPRF, RASA2, SIRPG, RGS2, RAP2A, RAB2B, ARL17, SERINC4, XIAP, DENND4C, ANKRA2, CSTA, STX18, and SNAP23. An integrated analysis of Enrich Shiny Gene Ontology (GO), STRING, and Cytoscape was used to identify potential molecular interactions and key pathways. Functional enrichment analysis showed significant changes in biological processes such as the regulation of protein metabolic processes and small GTPase-mediated signal transduction, as well as changes in molecular functions related to GPCR activity, guanyl ribonucleotide binding, GTPase activity, and nucleoside-triphosphatase activity. Similar findings were observed in Sertoli cells. The identified gene mutations could potentially be used to develop new receptor-selective GPCR antagonists or agonists,
    Pubmed: 37610843   DOI: 10.1089/dna.2023.0189

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare